Journal of Fluorescence

, Volume 21, Issue 4, pp 1371–1384 | Cite as

Conventional and First Derivative Synchronous Fluorometric Determination of Ethamsylate in Pharmaceutical Preparations and Biological Fluids. Application to Stability Studies

  • Fathalla Belal
  • Amina El-Brashy
  • Nahed El-Enany
  • Manar Tolba
Original Paper


Two simple, accurate and highly sensitive spectrofluorometric methods were developed for the determination of ethamsylate (ETM). Method I is based on measuring the native fluorescence of ethamsylate in water at 354 nm after excitation at 302 nm. The calibration plot was rectilinear over the range of 0.05–1 μg/mL for ETM with limits of detection and quantitation of 7.9 and 26 ng/mL, respectively. Method II involved synchronous and first derivative synchronous fluorometric methods for the simultaneous determination of ethamsylate (ETM) and hydroquinone (HQ) which is considered as an impurity and/or acidic degradation product. The synchronous fluorescence of both the drug and its impurity were measured in methanol at Δ λ of 40 nm. The peak amplitudes (1D) were estimated at 293.85 or 334.17 nm for ETM and at 309.05 nm for HQ. Good linearity was obtained for ETM over the ranges 0.1–1.4 μg/mL and 0.1–1.0 μg/mL at 293.85 and 334.17 nm, respectively. For HQ, the calibration plot was rectilinear over the range of 0.01–0.14 μg/mL at 309.05 nm. Limits of detection were 20, 2.01 ng/mL and limits of quantitation were 60, 6.7 ng/mL for ETM and HQ by method II, respectively. Both methods were successfully applied to commercial ampoules and tablets. The results were in good agreement with those obtained by the reference method. Method I was utilized to study the stability of ETM and its degradation kinetics using peroxide. The apparent first-order rate constant, half-life times and activation energy of the degradation process were calculated. Method I was further extended to the in-vitro and in-vivo determination of ETM in spiked and real plasma samples. The mean% recoveries were 99.57 ± 3.85 and 89.39 ± 5.93 for spiked and real human plasma, respectively.


Ethamsylate Hydroquinone Synchronous fluorimetry Human plasma Stability study Degradation-kinetics 


  1. 1.
    Sweetman SC (ed) (2007) Martindale, the complete drug reference, 35th edn. Pharmaceutical Press, London, p 959Google Scholar
  2. 2.
    The British Pharmacopoeia (2007) The Stationery Office: London; Electronic versionGoogle Scholar
  3. 3.
    Kaul N, Agrawal H, Kakad A, Dhaneshwar SR, Patil B (2005) Stress degradation studies on etamsylate using stability-indicating chromatographic methods. Anal Chim Acta 536(1–2):49–70CrossRefGoogle Scholar
  4. 4.
    Zhang M, Zhang Y, Li Q (2010) A novel visible spectrophotometric method for the determination of ethamsylate in pharmaceutical preparations and biological samples. Spectrochim Acta A 75(3):1013–1017CrossRefGoogle Scholar
  5. 5.
    Goyal A, Singhvi I (2008) Spectrophotometric estimation of ethamsylate and mefenamic Acid from a binary mixture by dual wavelength and simultaneous equation methods. Indian J Pharm Sci 70(1):108–111PubMedCrossRefGoogle Scholar
  6. 6.
    El-Enany N, Belal F, Rizk M (2007) Kinetic spectrophotometric determination of ethamsylate in dosage forms. J AOAC Int 90(3):679–685PubMedGoogle Scholar
  7. 7.
    El-Shabrawy Y, El-Enany N, Salem K (2004) Sensitive kinetic spectrophotometric determination of captopril and ethamsylate in pharmaceutical preparations and biological fluids. Farmaco 59(10):803–808PubMedCrossRefGoogle Scholar
  8. 8.
    Xu ZC, Li XY, Shi J, Yao XJ, Liu AZ, He ZS (1994) Determination of Dicynone [ethamsylate] in gastric mucosa by ultra-violet spectrophotometry. Fenxi Huaxue 22(4):420Google Scholar
  9. 9.
    Jaiswal YS, Talele GS, Surana SJ (2005) Quantitative analysis of ethamsylate and mefenamic acid in tablets by use of planar chromatography. J Planar Chromatogr Mod TLC 18(106):460–464CrossRefGoogle Scholar
  10. 10.
    Jaiswal YS, Talele GS, Surana SJ (2005) A simple and sensitive HPTLC method for quantitative analysis of ethamsylate in tablets. J Planar Chromatogr Mod TLC 105(18):380–383CrossRefGoogle Scholar
  11. 11.
    Ma J, Liu Y (1984) Quantitative analysis of etamsylate by h.p.l.c. Yaowu Fenxi Zazhi 4(4):209–211Google Scholar
  12. 12.
    Wang SF, Xu Q (2007) Electrochemical parameters of ethamsylate at multi-walled carbon nanotube modified glassy carbon electrodes. Bioelectrochemistry 70(2):296–300PubMedCrossRefGoogle Scholar
  13. 13.
    Wang ZH, Li ZG, Zhou SP (2005) Voltammetric behavior of embedded super-thin carbon film electrode and its application. Fenxi Huaxue 33(4):523–526Google Scholar
  14. 14.
    Zhang XH, Wang SF (2005) Determination of ethamsylate in the presence of catecholamines using 4-amino-2-mercaptopyrimidine self-assembled monolayer gold electrode. Sens Actuators B 104(1):29–34CrossRefGoogle Scholar
  15. 15.
    Wang ZH, Zhang D, Zhang Y, Zhou SP (2001) Voltammetric behaviour of Dicynone at a poly(4-aminopyridine) film-modified electrode and its determination by adsorptive stripping voltammetry. Fenxi Huaxue 29(1):83–86Google Scholar
  16. 16.
    Yang FZ, Zhang C, Baeyens WRG, Zhang XR (2002) Determination of ethamsylate in pharmaceutical preparations based on an auto-oxidation chemiluminescence reaction. J Pharm Biomed Anal 30(3):473–478PubMedCrossRefGoogle Scholar
  17. 17.
    Li YH, Du JX, Lu JR (2002) Chemiluminescence reaction of luminol-[potassium ferricyanide-potassium ferrocyanide]-ethamsylate system. Fenxi Huaxue 30(6):742–744Google Scholar
  18. 18.
    Du JX, Li YH, Tang Y, Lu JR (2002) Flow-injection chemiluminescence determination of ethamsylate based on permanganate oxidation. Anal Lett 35(3):463–472CrossRefGoogle Scholar
  19. 19.
    Zhang CX, Huang JC, Feng ML, Zhang ZJ (1998) Flow injection chemiluminescence determination of etamsylate with electrogenerated hypochlorite. Anal Lett 31(11):1917–1928Google Scholar
  20. 20.
    Li J, Ju H (2006) Simultaneous determination of ethamsylate, tramadol and lidocaine in human urine by capillary electrophoresis with electrochemiluminescence detection. Electrophoresis 27(17):3467–3474PubMedCrossRefGoogle Scholar
  21. 21.
    Skoog DA, Holler FJ, Crouch SR (2007) Principles of instrumental analysis, 6th edn. Thomson, Belmont, p 406Google Scholar
  22. 22.
    Miller JN, Miller JC et al (2005) Statistics and chemometrics for analytical chemistry. Pearson Education Limited, Harlow, pp 39–73, 107–149, 256Google Scholar
  23. 23.
    ICH Harmonized Tripartite Guideline, Validation of Analytical Procedures: Text and Methodology, Q2(R1), Current Step 4 Version, Parent Guidelines on Methodology Dated November 6 1996, Incorporated in November 2005. (accessed February 15, 2008).
  24. 24.
  25. 25.
    Sun Y, Nakashima MN, Takahashi M, Kuroda N, Nakashima K (2002) Determination of bisphenol A in rat brain by microdialysis and column switching high-performance liquid chromatography with fluorescence detection. Biomed Chromatogr 16:319–326PubMedCrossRefGoogle Scholar
  26. 26.
    Martin A, Bustamante P (1993) Physical pharmacy, 4th edn. Lea and Febiger, Pheladelphia, p 295Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Fathalla Belal
    • 1
  • Amina El-Brashy
    • 1
  • Nahed El-Enany
    • 1
  • Manar Tolba
    • 1
  1. 1.Department of Analytical Chemistry, Faculty of PharmacyUniversity of Mansoura35516 MansouraEgypt

Personalised recommendations